Edition:
United States

Sanochemia Pharmazeutika AG (SCPH.VI)

SCPH.VI on Vienna Stock Exchange

1.63EUR
25 Sep 2017
Change (% chg)

-- (--)
Prev Close
€1.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,643
52-wk High
€1.84
52-wk Low
€1.32

Latest Key Developments (Source: Significant Developments)

Sanochemia Pharmazeutika 9-month sales at EUR 27.2 million
Thursday, 24 Aug 2017 04:56am EDT 

Aug 24 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG :9-MONTH SALES AMOUNTED TO EUR 27.2 MILLION (PREVIOUS YEAR: EUR 26.7 MILLION).  Full Article

Sanochemia Pharmazeutika: published data confirm advantage of Tolperison vs other muscle relaxants
Tuesday, 18 Jul 2017 07:12am EDT 

July 18 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG ::PUBLISHED DATA CONFIRM THE ADVANTAGE OF TOLPERISON COMPARED TO OTHER MUSCLE RELAXANTS.  Full Article

Sanochemia Pharmazeutika swings to EBIT loss of EUR 899,000
Tuesday, 23 May 2017 05:49am EDT 

May 23 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG ::H1 SALES INCREASED FURTHER - FROM EUR 17.515 MILLION IN THE PREVIOUS YEAR TO EUR 18.647 MILLION.H1 EBIT LOSS AT EUR 899,000 (PREVIOUS YEAR: PROFIT EUR 370,000).REAFFIRMS GROWTH STRATEGY AND THE FINANCIAL OBJECTIVE FOR 2016/17: ORGANIC GROWTH BASED ON THE EXISTING STRENGTHS IN THE CORE SEGMENTS, AS WELL AS A POSITIVE EBIT.  Full Article

Sanochemia Pharmazeutika Q1 2016/17 total revenues EUR 6.9 mln
Thursday, 23 Feb 2017 02:59am EST 

Sanochemia Pharmazeutika AG : Q1 FY 2016/17 total revenues as at Dec. 31, 2016 amounted to 6.867 million euros ($7.25 million) (previous year: 6.865 million euros) .As the annual target, further growth in sales compared to the previous year, as well as a positive EBIT and operating result.  Full Article

Sanochemia Pharmazeutika FY EBIT down at 713,000 euros
Thursday, 19 Jan 2017 03:45am EST 

Sanochemia Pharmazeutika AG : FY EBIT: 713,000 euros (previous year: 1.646 million euros) . FY revenue 39.3 million euros versus 35.6 million euros year ago .FY loss after tax: 555,000 euros (previous year: profit 384,000 euros).  Full Article

Sanochemia Pharmazeutika awarded patent for Vidon Photodynamic Diagnosis of bladder cancer in the USA
Friday, 13 Jan 2017 02:15am EST 

Sanochemia Pharmazeutika AG : Grant of patent for Vidon Photodynamic Diagnosis of bladder cancer in the USA .U.S. patent will protect Vidon until 2035.  Full Article

Sanochemia Pharmazeutika H1 turnover up 12 pct at 26.68 million euros
Friday, 26 Aug 2016 02:00am EDT 

Sanochemia Pharmazeutika AG : Total turnover was up at 30 June 2016 compared to previous year by 12 pct to 26.681 million euros (previous year: 23.900 million euros) .Sees FY revenue growth of 10 pct compared to the fiscal year 14/15.  Full Article

Sanochemia Pharmazeutika announces partnership for research into immune oncology therapeutics
Monday, 18 Jul 2016 04:45am EDT 

Sanochemia Pharmazeutika AG :Announces a partnership for research into immune oncology therapeutics.  Full Article

Sanochemia Pharmazeutika announces cooperation with b.e.imaging and SPL Medical B.V.
Thursday, 16 Jun 2016 06:30am EDT 

Sanochemia Pharmazeutika AG :Announces cooperation with b.e.imaging and SPL Medical B.V..  Full Article

Sanochemia Pharmazeutika H1 sales up 7 percent to 17.515 million euros
Tuesday, 31 May 2016 02:08am EDT 

Sanochemia Pharmazeutika AG : H1 sales increase of 7 percent to 17.515 million euros ($19.50 million) (previous year: 16.349 million euros) . H1 EBIT of 370,000 euros versus 878,000 euros year ago .Sees for current fiscal year of a 10 pct growth in turnover.  Full Article

BRIEF-Sanochemia Pharmazeutika: start of a Phase I trial sponsored by Neurana

* PTA-NEWS: SANOCHEMIA PHARMAZEUTIKA AG: SANOCHEMIA - TOLPERISONE USA: START OF CLINICAL PHASE-I TRIAL